Blood tests can flag a surprising number of stomach problems, from infections and ulcers to chronic inflammation and even early signs of gastric cancer, though no single tube of blood replaces looking inside the stomach directly. A standard complete blood count can reveal anemia hinting at hidden bleeding, while specialized panels measuring pepsinogen and gastrin levels can identify thinning of the stomach lining with accuracy that rivals a biopsy in some cases. The real picture is layered: some stomach conditions show up clearly in blood work, others leave only faint traces, and a few remain invisible to any blood test currently available.
What a Standard Blood Count Can Tell You
The most commonly ordered blood test in medicine, the complete blood count, is also the first clue that something may be wrong in the stomach. It measures red blood cells, white blood cells, and platelets, and the patterns it reveals can point toward gastric trouble even when you went to the lab for a completely different reason.
Iron-deficiency anemia, shown by low hemoglobin and small red blood cells, is one of the classic tip-offs. Chronic bleeding from a stomach ulcer, erosive gastritis, or a gastric tumor can slowly drain iron stores without producing obvious symptoms like vomiting blood. In fact, unexplained iron-deficiency anemia in adults, especially men and postmenopausal women, is an established trigger for doctors to investigate the gastrointestinal tract.
Beyond anemia, inflammatory ratios derived from the same blood count have gained attention as markers for gastric ulcers. Ratios like the neutrophil-to-lymphocyte ratio and the systemic inflammatory response index rise in patients with gastric ulcers, reflecting the immune system’s reaction to mucosal damage. Research has identified the systemic inflammatory response index as a particularly strong predictor of gastric ulcer prevalence among these simple, inexpensive markers.1PubMed Central. Complete blood count-derived inflammatory indices: A noninvasive aid for risk stratification in gastric ulcer These ratios are not specific to stomach ulcers alone, though. They reflect systemic inflammation, so an elevated reading could stem from anything from a urinary tract infection to a flare of inflammatory bowel disease.2PubMed Central. Systemic inflammatory markers in gastric ulcer: Leveraging routine blood tests They are best understood as a red flag that warrants further investigation, not a standalone diagnosis.
C-reactive protein, another common blood marker of inflammation, also tends to be elevated when active gastric disease is present. Studies of patients with Helicobacter pylori infection have shown that CRP levels drop significantly after the infection is successfully treated, along with improvements in the platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio.3Akademik Gastroenteroloji Dergisi. Effect of eradication treatment for Helicobacter pylori on complete blood count and inflammatory parameters Watching these markers decline after treatment can confirm that the infection was the source of the inflammation.
Pepsinogen and Gastrin Panels for Stomach Lining Health
If the standard blood count is a smoke detector, then pepsinogen and gastrin panels are more like a targeted scan of the stomach wall itself. These proteins are produced by specific cells in the stomach lining, so measuring their levels in blood gives doctors a surprisingly detailed picture of what the mucosa looks like without sending a camera down your throat.
Pepsinogen I is made mainly by cells in the upper stomach (the corpus), while gastrin-17 is produced by cells in the lower stomach (the antrum). When chronic inflammation thins out one region, the corresponding marker drops. A multicenter study found that combining pepsinogen I, gastrin-17, and H. pylori antibody measurements could detect advanced atrophic gastritis with about 83% sensitivity and 95% specificity, lining up well with what biopsies showed.4PubMed. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study Those are strong numbers for a blood draw, and they explain why several countries, particularly in East Asia and Northern Europe, use these panels as population-level screening tools.
More recent work confirms that these markers track with the severity of chronic atrophic gastritis. As the stomach lining worsens, pepsinogen I and the pepsinogen I-to-II ratio fall while gastrin-17 and pepsinogen II rise. Combining all four markers together yields an area under the curve of about 0.72 for detecting any degree of chronic atrophic gastritis, with higher accuracy for more severe disease.5PubMed Central. The potential value of serum pepsinogen and gastrin-17 for the diagnosis of chronic atrophic gastritis at different stages of severity: a clinical diagnostic study The takeaway is that the blood test works best at catching the patients who need endoscopy most urgently, namely those with advanced atrophy that carries the highest risk of progressing toward gastric cancer.
For autoimmune gastritis specifically, where the body’s immune system attacks the acid-producing parietal cells of the stomach, the blood picture is distinctive. Pepsinogen I drops steeply, the pepsinogen I-to-II ratio plummets, and gastrin levels soar because the antrum’s G-cells ramp up in response to the loss of acid production. A study evaluating these markers in autoimmune gastritis found that pepsinogen I below about 20 ng/mL and a gastrin level above 355 pg/mL were strong predictors, with areas under the curve above 0.9.6Scientific Reports. Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis
Testing for H. pylori Through Blood
H. pylori is the bacterium behind most stomach ulcers and a major driver of chronic gastritis and gastric cancer risk worldwide. Blood-based antibody tests for H. pylori are widely available, but they come with a well-known limitation: they cannot tell the difference between a current infection and one you cleared years ago. Antibodies to H. pylori can linger in the blood for months or even years after the bacterium is gone.
Because of this, the breath test (urea breath test) and stool antigen test are generally preferred for diagnosing active infection. A comparative study found that the breath test had an accuracy of about 96%, while standard serology came in around 86%.7PubMed Central. Reliability of Diagnostic Tests for Helicobacter pylori Infection That gap matters clinically, especially when the goal is deciding whether to prescribe antibiotics.
Newer blood-based rapid tests are trying to narrow that accuracy gap. One approach detects antibodies to two specific H. pylori proteins, FliD and CagA, and achieved a sensitivity of 100% and a specificity of about 88% in validation testing.8Gastroenterology. New Rapid Helicobacter Pylori Blood Test Based on Dual Detection of FliD and CagA Antibodies for On-Site Testing While promising, this still did not fully match the breath test, and distinguishing current from past infection remains a challenge for any antibody-based method.
Where serology still earns its place is in large-scale screening programs and in situations where breath or stool testing is impractical. It also has a role in the pepsinogen-gastrin panel mentioned earlier, where H. pylori antibody status helps interpret the other markers. And in children, diagnosing H. pylori requires extra caution, because the infection presents differently than in adults, and test accuracy can vary with age.9PubMed Central. Updates on the Diagnosis of Helicobacter pylori Infection in Children: What Are the Differences between Adults and Children?
Autoimmune Gastritis and Parietal Cell Antibodies
Autoimmune gastritis is an underdiagnosed condition where the immune system gradually destroys the stomach’s acid-producing cells. Over time, this leads to low acid, poor absorption of vitamin B12 and iron, and a heightened risk of both gastric cancer and neuroendocrine tumors. Blood work is central to catching it.
The hallmark blood marker is the anti-parietal cell antibody, which targets an enzyme in the stomach’s acid-secreting machinery. These antibodies are found in roughly 85 to 90% of patients with pernicious anemia, the end-stage consequence of autoimmune gastritis.10PubMed. Anti-parietal cell antibodies – diagnostic significance Newer, more specific assays target the exact protein involved, H+/K+ ATPase, and may improve diagnostic precision compared with older tests.11PubMed Central. Improving the Diagnosis of Autoimmune Gastritis: From Parietal Cell Antibodies to H+/K+ ATPase Antibodies
Because autoimmune gastritis quietly destroys the cells that make intrinsic factor, the protein needed to absorb vitamin B12, low B12 on a blood test is often the first sign. Measuring B12 alone can be misleading, though, as levels can appear borderline even when a true functional deficiency exists. More refined markers like holotranscobalamin and methylmalonic acid can help pin down whether B12 status is genuinely inadequate.12BMJ. Vitamin B12 deficiency If your doctor finds low B12, low iron, and positive parietal cell antibodies on the same blood panel, autoimmune gastritis moves high on the list of suspects.
Blood Tests and Gastric Cancer
For gastric cancer specifically, the honest answer is that conventional blood tumor markers do a poor job at early detection. The markers most commonly used, including CEA, CA19-9, and CA72-4, are positive in only about 21% to 30% of confirmed gastric cancer cases overall.13PubMed. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association That means the majority of patients with early gastric cancer would be missed if doctors relied on these markers alone. Their role in practice is not in screening or early diagnosis but rather in monitoring for recurrence after surgery and tracking response to treatment.
A diagnostic model combining multiple tumor markers found that the individual markers each had limited sensitivity, ranging from about 32% to 67%, confirming their inadequacy as standalone screening tools.14PubMed Central. Construction and Validation of a Gastric Cancer Diagnostic Model based on Blood Groups and Tumor Markers The broader picture in oncology is that tumor marker standardization for gastric cancer remains a work in progress.15PubMed Central. Classic tumor markers in gastric cancer. Current standards and limitations
The frontier of blood-based cancer detection lies in liquid biopsy, which looks for fragments of tumor DNA (circulating tumor DNA) or tiny RNA molecules (microRNAs) shed into the bloodstream by cancer cells. Early research suggests these approaches could improve early diagnosis, allow population-level screening, and help personalize treatment decisions for gastric cancer.16PubMed. Circulating miRNA and circulating tumor DNA application as liquid biopsy markers in gastric cancer These are not yet standard clinical tools, but they represent the direction the field is moving, and multi-cancer early detection blood tests are already entering clinical trials for broader populations.
When Elevated Gastrin Points to a Gastrinoma
A fasting serum gastrin level is one of the most targeted blood tests for a specific gastric condition. Gastrinomas, the rare tumors that cause Zollinger-Ellison syndrome, drive the stomach to produce massive amounts of acid, leading to severe ulcers that resist standard treatment. Measuring fasting gastrin is the initial diagnostic step, and the test is remarkably sensitive, catching about 99% of cases.17PubMed. All you need to know about gastrinoma today
The interpretation requires nuance, though. A gastrin level above 1,000 pg/mL combined with a stomach pH below 2 is considered diagnostic, but about two-thirds of patients with Zollinger-Ellison syndrome have fasting gastrin levels that overlap with values seen in other conditions, such as chronic use of proton pump inhibitors, which also raise gastrin.18PubMed Central. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health For those borderline cases, a secretin stimulation test is used: secretin is injected intravenously, and if gastrin levels spike sharply afterward, a gastrinoma is likely. The secretin test is considered the best provocative test for separating Zollinger-Ellison syndrome from other causes of high gastrin.19PubMed. Management of patients with Zollinger-Ellison syndrome
Blood Tests That Reveal Neighboring Organ Problems Mimicking Stomach Pain
Stomach pain is not always a stomach problem, and blood work plays a crucial role in sorting out the source. Acute pancreatitis, which often feels like severe upper abdominal or epigastric pain, is diagnosed primarily through blood levels of amylase and lipase. Lipase is now the preferred test because it performs better, especially in alcohol-related cases. A level two to four times the upper limit of normal, combined with characteristic pain, is enough to establish the diagnosis without imaging in many cases.20PubMed Central. Blood tests for acute pancreatitis
Thyroid function tests matter here too. Hypothyroidism can slow gastric motility, producing bloating, nausea, and a sense of fullness that feels indistinguishable from gastroparesis or functional dyspepsia. Checking thyroid-stimulating hormone is a reasonable step when stomach symptoms are vague and persistent, particularly if other gastric tests have come back normal.21PubMed. Current concepts in gastric motility in diabetes mellitus Similarly, poorly controlled diabetes causes gastroparesis through nerve damage, and a hemoglobin A1c test can reveal whether chronically high blood sugar is contributing to slow stomach emptying.
Conditions Where Blood Work Gives Misleading Reassurance
Not every stomach condition leaves a footprint in the blood. Eosinophilic gastritis is a condition where eosinophils, a type of white blood cell associated with allergic and immune reactions, infiltrate the stomach wall. You might expect the blood to show elevated eosinophils, and in one study it did correlate strongly: patients with eosinophilic gastritis had blood eosinophil counts more than ten times higher than controls.22PubMed Central. Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome But another case series found that only about 29% of patients with eosinophilic gastroenteritis actually had elevated blood eosinophils.23PubMed Central. Diagnosis of eosinophilic gastroenteritis is easily missed The discrepancy likely reflects differences in disease severity and distribution. The practical lesson is that normal blood eosinophils do not rule out eosinophilic gastritis, and the diagnosis still requires biopsies during endoscopy.
Functional dyspepsia, the most common cause of chronic stomach discomfort, typically produces entirely normal blood work. There is no blood marker for it. The diagnosis is made by ruling out structural and biochemical causes, which is frustrating for patients who feel genuinely unwell but keep getting told their tests are normal.
Gastric erosions caused by NSAID use, like ibuprofen or diclofenac, may not register on blood tests until enough slow bleeding has occurred to produce anemia. In two large clinical trials, patients taking diclofenac were roughly two to three times more likely to develop a clinically meaningful drop in hemoglobin compared to those on the safer alternative celecoxib.24PubMed Central. NSAIDs and Anaemia Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials So blood work may eventually catch NSAID-related damage, but it can take months of ongoing injury before the hemoglobin drops enough to trigger alarm.
Celiac Disease Antibodies and the Stomach
Celiac disease is usually thought of as a small-intestine problem, but it overlaps with the stomach more than most people realize. Blood tests for celiac, particularly tissue transglutaminase antibodies and endomysial antibodies, are highly accurate screening tools. What is less well known is that celiac disease and peptic ulcers can coexist. In one study of children with confirmed peptic ulcers, 29% also tested positive for celiac antibodies, a rate far higher than in the general population.25PubMed. Frequency of Celiac Disease in Children with Peptic Ulcers This means that blood work checking for celiac may be worth considering when stomach ulcers are found in someone without the usual risk factors like H. pylori or NSAID use.
Why IgG Food Sensitivity Panels Are Not the Answer
If you have chronic stomach symptoms and have been tempted by direct-to-consumer “food sensitivity” blood tests that measure IgG or IgG4 antibodies to dozens of foods, the evidence says to save your money. The European Academy of Allergy and Clinical Immunology has concluded that food-specific IgG4 does not indicate food allergy or intolerance. Instead, IgG4 simply reflects that your immune system has encountered that food repeatedly, which is a normal, expected response, not a sign of a problem.26PubMed. Testing for IgG4 against foods is not recommended as a diagnostic tool: EAACI Task Force Report Many people with no symptoms at all test positive for IgG4 against common foods, and eliminating those foods based on test results can lead to unnecessarily restrictive diets without resolving the actual stomach issue.
The broader landscape of direct-to-consumer lab testing raises similar concerns. Without medical interpretation, test results can easily be misread, leading to unnecessary anxiety or false reassurance.27PubMed Central. Direct to Consumer Laboratory Testing (DTCT) – Opportunities and Concerns A positive result on a poorly validated test can send you down a rabbit hole of elimination diets and follow-up panels, while the actual cause of your symptoms, whether it is H. pylori, autoimmune gastritis, or something else entirely, goes uninvestigated.
Emerging Blood-Based Approaches
Research into the gut microbiome is beginning to intersect with blood-based diagnostics in interesting ways. Patients with H. pylori-related gastritis show altered levels of certain metabolites in their blood, including short-chain fatty acids like isovaleric acid, which appear connected to shifts in gut bacteria such as Bacteroides, Fusobacterium, and Prevotella.28PubMed. Metabolic alterations in patients with Helicobacter pylori-related gastritis: The H. pylori-gut microbiota-metabolism axis in progression of the chronic inflammation in the gastric mucosa The idea of an “H. pylori-gut microbiota-metabolism axis” is still a research concept rather than a clinical tool, but it hints at a future where a blood metabolite profile could characterize the state of your stomach and gut ecosystem in a single draw.
Similarly, liquid biopsy techniques that detect circulating tumor DNA and microRNAs are being studied for earlier gastric cancer detection. If validated at scale, these tests could shift the paradigm from relying on endoscopic screening, which is expensive and invasive, toward population-level blood screening in regions where gastric cancer is common. For now, though, they remain investigational, and endoscopy with biopsy remains the gold standard for diagnosing most structural stomach diseases.